CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Sodium Bicarbonate Oral Capsule +1 moredrug
Likely dose
Sodium Bicarbonate Oral Capsule 1680 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02501343
NCT02501343N/ACompleted

Alkaline Diet for Insulin Sensitivity

Garvan Institute of Medical Research·interventional·Posted Jul 17, 2015·Updated Mar 7, 2017

In Brief

A clinical study evaluating Sodium Bicarbonate Oral Capsule and Placebo for Dysglycemia and Type 2 Diabetes Mellitus. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to test the effect of increasing the body pH acutely with an alkaline medication (sodium bicarbonate, NaHCO3, sodibic) on glucose metabolism post meal in non diabetic subjects with normal renal function. The investigators aim to determine whether there is an acute reduction in venous blood pH following a typical Western-style (high acid load) breakfast in healthy men and women, and whether this effect is attenuated by the concurrent administration of an alkaline medication. The effect on glucose metabolism, hunger/satiety and arterial stiffness post meal will be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 17, 2015
Enrollment StartMar 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.0 years ago

Interventions

Sodium Bicarbonate Oral Capsuledrug

Sodium bicarbonate 1680 mg will be administered prior to the meal

Placebodrug

Sodibic-matching placebo (Stenlake Compounding Chemist, NSW, Australia) will be administered prior to the meal on a different day 1 to 2 weeks apart